Dynorphin-(1–13): The effect of in vivo treatment on opiate bindings in vitro (original) (raw)
[3H] dynorphin binding to guinea pig and rat brain
Huda Akil
Life Sciences, 1983
View PDFchevron_right
Dynorphin-(1–13): Effects in nontolerant and morphine-dependent rhesus monkeys
Mario D Aceto
European Journal of Pharmacology, 1982
View PDFchevron_right
Opiate modulation of dynorphin conversion in primary cultures of rat cerebral cortex
Jerzy Silberring
Brain Research, 1997
View PDFchevron_right
Identification of stabilized dynorphin derivatives for suppressing tolerance in morphine-dependent rats
Boglarka Brugos
Pharmaceutical research, 2004
View PDFchevron_right
Possible regulatory role of dynorphin-(1–13) on narcotic-induced changes in naloxone efficacy
Cankat Tulunay
European Journal of Pharmacology, 1981
View PDFchevron_right
Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal
I. Nylander
Brain Research, 1995
View PDFchevron_right
The effect of a paracetamol and morphine combination on dynorphin A levels in the rat brain
Sanzio Candeletti, Patrizia Romualdi
Biochemical Pharmacology, 2001
View PDFchevron_right
The degradation of dynorphin A in brain tissue in vivo and in vitro
Huda Akil
Peptides, 1987
View PDFchevron_right
Stabilized dynorphin derivatives for modulating antinociceptive activity in morphine tolerant rats: Effect of different routes of administration
Guenther Hochhaus
The AAPS Journal, 2004
View PDFchevron_right
The effect of a paracetamol and morphine combination on dynorphin A levels in the rat brain44Abbreviations: NSAIDs, non-steroidal anti-inflammatory drugs; DYN, dynorphin; PARA, paracetamol; and ir-DYN, immunoreactive dynorphin
Patrizia Romualdi
Biochemical Pharmacology, 2001
View PDFchevron_right
Dynorphin B-29: Chemical synthesis and pharmacological properties in opioid systems
Patricia Sanchez-Blazquez
Neuropeptides, 1984
View PDFchevron_right
Pressor, tachycardic and feeding responses in conscious rats following i.c.v. administration of dynorphin. Central blockade by opiate and α1-receptor antagonists
J. Thornhill
Regulatory Peptides, 1987
View PDFchevron_right
Binding of dynorphin A and related peptides to κ- and μ-opioid receptors: sensitivity to Na+ ions and Gpp(NH)p
jean cros
European Journal of Pharmacology: Molecular Pharmacology, 1989
View PDFchevron_right
Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on μ-receptors in the CA1 region
George Siggins, Steven Henriksen
Brain Research, 1985
View PDFchevron_right
The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine
Fishman Jordan
Life Sciences, 1993
View PDFchevron_right
Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: further evidence for two μ-binding sites
Kenner Rice
European Journal of Pharmacology, 1989
View PDFchevron_right
Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin
Iain James
Proceedings of the National Academy of Sciences, 1982
View PDFchevron_right
The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1–13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat
Anil Rattan
Brain Research, 1993
View PDFchevron_right
Morphine tolerance increases μ-noncompetative δ binding sites
Janine Danks
European Journal of Pharmacology, 1986
View PDFchevron_right
Dynorphin A-( 1-13)-Tyr14Leu15-Phe16-Asn17-Gly18-Pro19: a potent and selective κ opioid peptide
Simon Lemaire
European Journal of Pharmacology, 1991
View PDFchevron_right
[3H]dynorphin a binding and κ selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain
Huda Akil
European Journal of Pharmacology, 1986
View PDFchevron_right
Increased dopamine receptor sensitivity in the rat following acute administration of sufentanil, U50,488H and d-Ala2-d-Leu5-enkephalin
Robert Sewell
Naunyn-Schmiedeberg's Archives of Pharmacology, 1991
View PDFchevron_right
Opioid agonist and antagonist treatment differentially regulates immunoreactive μ-opioid receptors and dynamin-2 in vivo
kaushal patel
European Journal of Pharmacology, 2004
View PDFchevron_right
Repeated electroconvulsive shock or chronic morphine treatment increases the number of 3HDALA2, DLEU5enkephalin binding sites in rat brain membranes
Gregory Belenky
Life Sciences, 1982
View PDFchevron_right
Studies on spinal opiate receptor pharmacology. III. Analgetic effects of enkephalin dimers as measured by cutaneous-thermal and visceral-chemical evoked responses
David Rodbard
Brain Research, 1985
View PDFchevron_right
Differential effect of humoral endorphin on the binding of opiate agonists and antagonists
Yosef Sarne
European Journal of Pharmacology, 1982
View PDFchevron_right
Opiate receptors: an introduction
John Carmody
Anaesthesia and intensive care, 1987
View PDFchevron_right
Opioid peptide dynorphin-(1–13): Adsorptive losses and potency estimates
Yao-kuang HO
Neuropeptides, 1980
View PDFchevron_right
Behavioral effects of dynorphin1–13 in the mouse and rat: Initial observations
Huda Akil
Peptides, 1980
View PDFchevron_right
Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography
Mária Wollemann, Jozsef Hepp
Journal of Neuroscience Research, 1990
View PDFchevron_right
Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration
Loan Lê
Pharmacology Biochemistry and Behavior, 2009
View PDFchevron_right
MOL-13185 1 Morphine-induced µ-opioid receptor desensitization MOL-13185 2 a. Running title Morphine-induced desensitization
Vu Dang
2020
View PDFchevron_right
Behavioral effects of dynorphin -- a novel opioid neuropeptide
Richard Katz
Neuropharmacology, 1980
View PDFchevron_right
Acute systemic administration of morphine selectively increases mu opioid receptor binding in the rat brain
Huda Akil
Neuropeptides, 1984
View PDFchevron_right